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Abstract
In women and laboratory animals, local and circulating components of the 
renin-angiotensin-aldosterone system (RAAS) are related to specific reproductive 
functions that occur during the estrous cycle, such as folliculogenesis, ovulation, 
corpus luteum development, and steroidogenesis. Also, in pregnant females of these 
species, maternal cardiovascular and renal systems undergo intense modifications, 
with the aim of matching the increased energy requirements of the fetus and fetopla-
cental unit. Some of these changes can be the origin, and others the consequence of 
a new endocrine environment. The fetus and the placenta induce endocrine changes, 
with modifications in the protein, lipid, carbohydrate, and mineral metabolism, 
together with simultaneous cardiovascular changes derived from the uterine growth 
and its content. The participation of RAAS during this period is of vital importance 
to regulate these cardiovascular, hemodynamic, hematological, and metabolic 
adjustments imposed by pregnancy because they will have a direct influence on 
the correct development and viability of the fetus. In mares, our research team has 
been investigating the changes of RAAS in mares during the estral cycle and during 
pregnancy, and these results are presented in the current chapter, comparing with 
the data previously reported for women and laboratory animals.
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1. Introduction
In nonpregnant females of various species, the components of the renin-angio-
tensin-aldosterone system (RAAS), i.e., prorenin, renin, angiotensin II (ANG-II), 
and aldosterone, are expressed in the tissues of reproductive organs, mainly the 
uterus and ovaries. These hormones have direct physiological relationships with 
specific reproductive functions, including folliculogenesis, oocyte maturation, 
ovulation, follicular atresia, corpus luteum development and luteolysis, steroido-
genesis, angiogenesis, and expression of certain vasoactive substances [1–8].
A great body of literature has confirmed an increase in plasma activity of renin 
(PRA) and plasma concentrations of ANG-II and aldosterone in women during the 
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luteal compared to the follicular period of the estrous cycle [9–19]. The primary 
source of renin and aldosterone is progesterone (P4) secreted by the corpus luteum. 
The elevated P4 concentrations during the luteal period lead to increased renal 
plasma flow, glomerular filtration rate, and natriuresis. This natriuretic effect 
stimulates in a compensatory way the synthesis and release of renin, ANG-II, and 
aldosterone [10–12, 15, 16, 20–23]. However, these results do not agree with those 
described by Szmuilowicz et al. [19], who suggested that the synthesis of aldo-
sterone might be independent of renin and ANG-II at the ovarian level. Another 
physiological event that happens during the estrous cycle of the women is the pre-
ovulatory increase of renin [14, 24], ANG-II [25], and aldosterone [10, 12, 25, 26].
Similar results to those described in women have been reported in laboratory 
animals [27–30]. A potential physiological mechanism related to these changes 
is the stimulatory effect exerted by estrogens (E2) on the synthesis of angioten-
sinogen [31]. Additional mechanisms could be the hemodynamic and renal blood 
flow variations, changes in Na concentrations at the macula densa in the kidney, 
alterations in local sympathetic activity, and release of corticotropin or adrenocor-
ticotrophic hormone (ACTH). All of these mechanisms act as regulatory factors for 
aldosterone synthesis [17, 19, 32, 33].
During pregnancy, circulating and tissular RAASs interact closely in order to 
achieve a successful outcome of the pregnancy. The local RAASs involved in preg-
nancy are mainly located at the ovaries, uterus (both at the placenta and decidua), 
and intrarenal level. The nonrenal local RAAS systems have pivotal functions in the 
implantation and in the placentation as well as in the development of the uteropla-
cental and umbilical placental circulations. In addition, they contribute directly 
to the circulating RAAS of the pregnant female, determining in part the normal 
functionality of the cardiovascular and renal systems [34].
In this review, we summarize the state of the art of the current knowledge of the 
RAAS in reproductive mares. We provide comparative profiling of the hormones 
of this system with other species, mainly with women and laboratory animals. 
The results of our own investigations performed during the last 10 years have 
demonstrated that an activation of the RAAS happens around ovulation and during 
pregnancy in the reproductive mare, even though significant differences with the 
reports made for women and laboratory animals have been found.
2.  Changes in the renin-angiotensin-aldosterone system during the  
estral cycle
2.1 A brief review of the estral cycle in the mare
An exhaustive review of the estral cycle of the mare and the neuroendocrine 
mechanisms associated has been published recently [35]. Briefly, the mean length of 
a mare’s estral cycle is 21 ± 3 days. The cycle is divided into two physiological periods: 
the estrous or follicular period and the diestrus or luteal period. The duration of the 
follicular period is approximately 6 days, but it can take 4–10 days depending on the 
mare. The luteal period has a duration of 15 days, ranging between 12 and 18 days. 
Ovulation can occur at any time during the follicular period, although it usually 
occurs 24–48 h before the end of this period. During the estral cycle, physiological 
changes in mares include follicular development, selection of the dominant follicle, 
release of the oocyte from follicle, formation of the corpus luteum, and production 
of P4. These physiological events are controlled by gonadotropin-releasing hormone 
(GnRH) that stimulates the hypophysis to secrete follicle-stimulating hormone 
(FSH) and luteinizing hormone (LH). These hormones control the development of 
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the follicle and stimulate the secretion of E2 from the follicle to induce ovulation and 
corpus luteum establishment and development [35, 36].
2.2 Changes in the renin-angiotensin-aldosterone system during the luteal period
Most researchers have documented that aldosterone concentrations rise between 
2 and 4 times during the luteal period [11, 37]. Presumably, this increase mirrors 
the increase experienced by ANG-II concentrations. However, this supposition has 
not always been supporting, and as a consequence, later it was suggested that the 
changes in ANG-II might be attributed to other ways independent of the RAAS 
[19]. Although this hypothesis is currently the most defended in the literature, some 
authors would not be able to confirm it [32, 38].
A variety of studies have shown that the relationship between PRA and aldo-
sterone from the middle to the end of the luteal period can be adjusted to a linear 
model [9, 10, 16, 22, 37, 39, 40]. The researches performed in women with luteal 
insufficiency have helped to clarify complex issues, such as the involvement of the 
sex hormones in the modifications of the different RAAS components during the 
different period of the estral cycle. In this sense, several early investigations com-
pared the concentrations of angiotensinogen, aldosterone, gonadotropins, ovarian 
steroids, and PRA in women with ovulatory cycles and in women with luteal insuf-
ficiency. While in physiological estral cycles the peak of PRA was closely related 
to the increase in aldosterone, in women with anovulatory cycles, these temporal 
relationships between renin and aldosterone or PRA and aldosterone were not 
found [9, 10, 41]. Subsequently, it was hypothesized that once the corpus luteum 
reaches functional maturity, it acts as the primary source of renin and aldosterone. 
Thereby, there was an explanation for the direct relationship between P4 and other 
compounds derived from the corpus luteum and the RAAS in physiological estral 
cycles, but not in women with ovulatory failure, because these women show a 
significant decrease in P4 concentrations [18, 21, 42].
P4 seems to be directly related to the luteal synthesis of aldosterone [15, 18, 21, 42]. 
Certain mechanisms dependent on P4, such as increased plasma flow, renal glomerular 
filtration rate, and Na and Cl excretion, result in natriuresis [16]. The initial natriuresis 
induced by P4 stimulates in a compensatory way the secretion of renin, ANG-II, and 
aldosterone [9–11, 20, 37]. The experimental administration of P4 results in natriure-
sis, which is followed by peaks of aldosterone secretion, aldosterone urinary excretion 
(AUE), and Na retention [11, 43]. Although PRA, ANG-II, and aldosterone increase 
after the administration of P4, the rises do not occur simultaneously [43]. These results 
have been explained in base of the competence between P4 and aldosterone for the 
mineralocorticoid receptor [12, 44, 45]. In physiological cycles, endogenously secreted 
P4 exerts a mild anti-aldosterone effect, avoiding an excessive retention of Na and 
water during the luteal period [46].
The E2 and P4 peaks during the luteal period lead to increases of PRA and 
ANG-II 2–3 times and also increases of AUE [17, 19]. However, the increase of E2 
that happens during the first half of the estral cycle does not result in substantially 
raised PRA and AUE. Perhaps these events are mediated by the expression of aldo-
sterone receptor protein and angiotensinogen in the absence of changes in ANG-II 
[46–48]. The lack of correlation between aldosterone and E2, as well as the lack 
of stimulation of aldosterone production in in vitro cultures of glomerulosa cells, 
could be other findings that might exclude E2 from the synthesis of aldosterone 
during the luteal period [19].
However, there are additional mechanisms involved in the synthesis of aldoste-
rone independently of the P4 concentrations, such as the uptake of proteins and Na 
in the diet [49, 50] or a peripheral vasodilation [16]. It is difficult to interpret these 
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findings without considering the intake of Na, since this electrolyte determines 
primarily the production of aldosterone via RAAS [49]. However, many previous 
studies did not control or did not report Na concentrations, which is a limiting 
factor in the proper interpretation of the results. More recently, Szmuilowicz et al. 
[19] showed that circulating and urinary levels of aldosterone increase significantly 
during the luteal period in response to the infusion of ANG-II in women with 
high Na concentrations. In these situations, positive correlations between P4 and 
aldosterone have been found, without parallel changes in PRA and ANG-II. On 
the contrary, in women with low Na concentrations, these interrelationships do 
not occur, even though the restriction of Na in the diet is a powerful stimulus for 
the activation of RAAS [49]. In Na-restricted diets, PRA and aldosterone respond 
independently between each other, and therefore, the absence of modifications in 
PRA and ANG-II could rule out that the increase in aldosterone is modulated via 
RAAS activation during the luteal period.
Another mechanism that has been related to the synthesis of renin and aldosterone 
during the luteal period is the release of angiotensinogen and prorenin. However, the 
studies conducted in this field have provided contradictory results. The expression 
of angiotensinogen is regulated transcriptionally by E2 [31], and consequently, the 
administration of different ovarian stimulation treatments in women increases the 
concentrations of E2 and renin [15]. Therefore, the activation of the RAAS during  
the luteal period could be partially related to the increased synthesis of angiotensinogen 
[21] or be a direct consequence of the vasodilatory effects of E2 [51]. However, early 
studies have not revealed variations in angiotensinogen during the luteal period of 
physiological estral cycles [10, 52, 53]. The combined use of E2 and P4 during the luteal 
period in ovariectomized rats resulted in increases in PRA without significant simulta-
neous changes in angiotensinogen [54]. The lack of a significant relationship between 
PRA and angiotensinogen might rule out E2 as a cause of the modifications in renin 
concentrations, despite its involvement in the secretion of aldosterone [10, 53, 55].
Although the main source of circulating active renin is the kidney, the ovaries 
appear to be the source of the cyclic increase of prorenin during the estral cycle 
[14, 56]. In fact, the release of LH triggers an increase of three times the concentra-
tions of prorenin, remaining elevated during the first half of the luteal period, 
even though the decrease in P4 at the end of the luteal period reduces simultane-
ously the prorenin levels [18, 21, 42, 56].
2.3  Changes in the renin-angiotensin-aldosterone system during the  
follicular period
Preovulatory increases of angiotensinogen, prorenin, PRA, renin, ANG-II, and 
aldosterone have been reported in women [11, 14, 25, 26] and laboratory animals 
[29]. According to other authors, the increase in aldosterone concentrations appears 
to be transient [11], or it is not constant in all cycles [37].
The origin of the preovulatory aldosterone peak is unknown, but it has been 
speculated that the increase in E2 could exert a stimulatory effect on angioten-
sinogen in the liver, and this, in turn, increases PRA and aldosterone [52, 53, 55]. 
Other researches, on the contrary, failed to find any relationship between angio-
tensinogen, PRA, and aldosterone in physiological cycles [11, 17, 19, 57], ruling out 
some type of significant influence of endogenous E2 on PRA and AUE during the 
periovulatory period [9, 10, 41]. Despite these contradictory results, the hypothesis 
that the increase in angiotensinogen is the cause of PRA and aldosterone peaks is 
still commonly accepted.
A transient peak of prorenin has been described simultaneously with the eleva-
tion of gonadotropins, mainly LH, toward the moment of the ovulation. It has been 
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speculated that this prorenin peak will be responsible later for the increase of active 
renin [58]. However, prorenin and LH are not always related to active renin [14, 15], 
because the most striking effects of this precursor appear toward the middle of the 
luteal period [18, 21, 42].
Because ACTH is one the main regulators of aldosterone secretion, the pre-
ovulatory peak of PRA might be related to the stimulatory effect of E2 on the 
adrenal gland and to the increase of the 17α-P4-enzyme, which also shows a 
preovulatory peak. This enzyme catalyzes the conversion of pregnenolone into 
17-α-hydroxypregnenolone, which is a precursor of the sexual steroids [59]. 
However, although an experimental infusion of ACTH triggers an elevation in PRA 
[60], the absence of changes in cortisol (CORT) concentrations in physiological 
cycles could refute these hypotheses [17, 19, 32]. Other factors, including hemody-
namic changes in renal blood flow, local sympathetic activity, and variation in Na 
concentrations at the macula densa level, have also been associated with the preovu-
latory peak of renin and aldosterone [33, 61].
In broodmares, Satué et al. [62] evaluated the changes in circulating RAAS 
components around ovulation, considering the 5 days before ovulation (from day 5 
to day 1), the day of the ovulation (day 0), and the 5 days immediately after ovula-
tion (from day 1 to day 5). A summary of the main endocrine changes, including 
those of the RAAS, is presented in Figure 1.
A progressive increase in plasma renin concentrations was found before ovula-
tion, peaking at the day of the ovulation [62] (Figure 2). The increase in plasma 
renin before ovulation in other species, as has been previously attributed to the 
release of LH or to the stimulating effect of human chorionic gonadotropin (hCG) 
[24]. Another plausible explanation for this rise in plasma renin before ovulation 
was the increase in E2 concentrations, since a positive correlation between both 
variables has been found in mares (r = 0.744) [62] (Figure 3). These results in 
mares agree with the data provided by Sealy et al. [15] in women with ovarian 
stimulation, in whom significant simultaneous increases in renin and E2 were 
detected. Another explanation for the rise in renin concentrations in the mares 
could be a mild hypovolemia associated with the presence of interstitial fluid in 
Figure 1. 
Representative scheme of the hormonal changes that occur in the mare during the 5 days before ovulation 
(preovulatory period), the day of the ovulation, and the last first 5 days after ovulation (postovulatory period) 
(ACTH, adrenocorticotrophic hormone; E2, estrogens; CORT, cortisol; P4, progesterone).
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abdominal cavity during ovulation. Even though changes in Na and Cl concentra-
tions at the renal juxtaglomerular apparatus significantly influence the release of 
renin [63], the correlations between renin and these electrolytes appear to be low 
in mares before ovulation [62]. In the same way, Roussel et al. [64] described cyclic 
patterns of plasma Na and aldosterone concentrations in cow, but without signifi-
cant correlations with the components of the RAAS.
After ovulation, a sharp decrease in plasma renin concentrations was detected in 
mares (Figure 2). Similar changes have been reported in women [17]. Ounis-Skali et al. 
Figure 2. 
Plasma renin concentrations during the 5 days before ovulation, the day of the ovulation, and the first 5 days 
after ovulation in mares (numbers indicate the days between which significant differences were found at 
p < 0.05).
Figure 3. 
Significant positive correlations between plasma estrogens (E2) and renin concentrations in mares before 
ovulation (r = 0.744).
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[18] attributed these results to the release of renin from the corpus luteum, reflecting a 
direct relationship between P4 and renin after ovulation, and similar hypotheses might 
be extrapolable to the mare. Two studies performed by our research team demonstrated 
low correlations between P4 and renin, suggesting other factors different from P4 might 
be considered in order to explain the non-significant trend toward an increase in renin 
concentrations during the first days after ovulation [65, 66].
Plasma ANG-II concentrations did not show significant variations before 
ovulation, but it experienced a sharp and progressive decrease after ovulation [62] 
(Figure 4). On the contrary, significant increases in ANG-II have been previously 
observed in sows [11] and in rats [29] before ovulation. ANG-II concentrations in 
women after ovulation were almost the double of the values found before ovulation 
[17–19]. This increase in women was attributed to the modulation of the flow in 
the ovarian blood vessels during oocyte maturation [15]. The reason why ANG-II 
concentrations decrease in the mares after ovulation, which is an opposite change to 
this described for women and laboratory animals, is not currently known.
Plasma aldosterone concentrations increased progressively from the fifth day 
before ovulation until the day of the ovulation. After this moment, aldosterone 
concentrations did not change and persisted to be significantly higher than before 
ovulation [62] (Figure 5). Because an increase in renin was also found the day of 
the ovulation in mares and ANG-II was higher during the 5 days before ovulation, 
it was speculated that the increased renin was the starting point to activate RAAS, 
resulting in increased aldosterone concentrations. This hypothesis was proven 
when the correlations between hormones before and after ovulation were assessed 
(Figure 6). A positive significant correlation (r = 0.756) was found between 
renin and aldosterone concentrations before ovulation. Surprisingly, ANG-II and 
aldosterone concentrations did not present a significant correlation before ovula-
tion (Figure 6). These data might indicate a dissociation between ANG-II and 
aldosterone before ovulation in the mare. In this case, the synthesis of aldosterone 
might have occurred in addition via other pathways independent from the activa-
tion of the RAAS [62].
Figure 4. 
Plasma angiotensin-II concentrations during the 5 days before ovulation, the day of the ovulation, and the first 
5 days after ovulation in mares (numbers indicate the days between which significant differences were found at 
p < 0.05).
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Figure 6. 
Correlations between the three main components of the renin-angiotensin-aldosterone system in mares before 
(A) and after ovulation (B).
Figure 5. 
Plasma aldosterone concentrations during the 5 days before ovulation, the day of the ovulation, and the first 5 
days after ovulation in mares (numbers indicate the days between which significant differences were found at 
p < 0.05).
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The relationships between the diameter of the predominant follicle and the 
hormones of the RAAS have also been investigated in mares [62] (Figure 7). A sig-
nificant positive correlation was found between renin and aldosterone concentrations 
and the diameter of the follicle before ovulation in the mares (r = 0.742 and 0.804, 
respectively) [62] (Figure 7). In other species, RAAS regulates the development and 
growth of the antral follicles. Receptors AT1 and AT2 for ANG-II have been found in 
the granulosa cells of the antral follicles and in the primordial primary and second-
ary follicles of sows [67]. Administration of an ANG-II inhibitor in cows avoided the 
growth of the predominant follicle and also induced a reduction in the concentrations 
of E2 [68, 69]. In the same way, in women subjected to ovarian stimulation with 
Figure 7. 
Correlations between the diameter of the predominant follicle (DPF) and the concentrations of renin, 
angiotensin II, and aldosterone before ovulation in mares.
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human menopausal gonadotropin (HMG), concentrations of ANG-II were positively 
correlated with E2 and the diameter of the predominant follicle [70]. In our research 
in mares, however, correlations between the diameter of the predominant follicle and 
ANG-II were very low (r = 0.366), despite the significant correlations between this 
diameter and the concentrations of renin and aldosterone [62] (Figure 7). Our results 
might suggest that circulating ANG-II concentrations do not exert a transcendental 
effect on the development of the ovarian follicle or, alternatively, some antagonist 
peptides of the ANG-II might be produced before ovulation in mares [65, 66].
3.  Changes in the renin-angiotensin-aldosterone system during  
the pregnancy
Plasma concentrations of prorenin increase by 5–10 times during the first 
10 weeks of pregnancy in women. This increase is simultaneous with the increase in 
hCG and after, both decreased until the moment of the delivery. Although prorenin 
is mainly synthesized in the renal juxtaglomerular cells, there are other extrarenal 
sources, such as the ovary, follicular fluid, and placenta [71]. The prorenin con-
centrations also increase when the LH concentrations peak at the moment of the 
ovulation [71, 72]. The combined administration of LH and FSH causes a 390% 
increase in plasma prorenin, while hCG increases above 1000% [13, 73]. An early 
study speculated that prorenin could act as a hormone with functions independent 
of the active renin [13]. Until now, to the authors’ best knowledge, the prorenin 
concentration in plasma/serum has not been quantified in mares.
A substantial increase in the circulating concentrations of angiotensinogen 
has also been documented during the first weeks of pregnancy in women [74]. 
Angiotensinogen concentrations remain elevated throughout pregnancy, peaking at 
term. In sheep, a bimodal pattern of secretion of this hormone has been described, 
with a first peak at the beginning of the pregnancy, concomitant with the period 
of the maximum placental growth. The second peak occurs at term, suggesting an 
association between plasma angiotensinogen and fetal growth [75].
The increased synthesis of angiotensinogen has been attributed to the stimulat-
ing effect of E2 at hepatic level [16, 17, 76]. However, the relationships between 
angiotensinogen and E2 are not always positive [77]. In nonpregnant women 
undergoing estrogen treatments, angiotensinogen and ANG-II increased in blood, 
whereas renin concentrations tended to decrease because of the negative feedback 
exercised by angiotensinogen [76]. However, the angiotensinogen concentrations 
have not been measured in mares yet.
The total concentration of circulating renin, both its active and inactive 
forms, increases during pregnancy in women. However, the contribution of the 
physiologically inactive renin to the total renin is greater than that of the active 
renin [78]. During the first third period of the pregnancy, renin concentra-
tions increased between 2 and 4 times above baseline [79, 80]. After it reaches a 
plateau, around the fifth month of pregnancy and after that, the concentrations 
remained unchanged until the end of the pregnancy [81], being the main reason 
involved in the rise of PRA during the first and second thirds of the pregnancy, 
respectively [11, 80, 82–84]. Toward the end of the pregnancy, the renin concen-
tration decreases intensely [78]. Even though the increased renin release con-
tributes greatly to the ANG-II synthesis, the renin concentrations could decrease 
because of a negative feedback mechanism [15, 85].
The synthesis of renin, in addition to renal juxtaglomerular cells, can also be 
carried out in other extrarenal tissues, as the uterus. This organ is the priority organ 
of renin synthesis during pregnancy, leading to the so-called hyperreninemia of the 
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pregnancy [80, 86]. The renin at the level of the fetal membranes and the uterus 
is found predominantly in the form of prorenin, and although it is supposed that 
it can be released into the maternal circulation, the degree of contribution to the 
maternal circulating levels is unknown. Both active renin and inactive renin have 
been identified in the uterus, placenta, and myometrium in women and in some 
laboratory animals [87]. Despite this, amniotic fluid seems to be the main source of 
renin produced by the chorionic cells during pregnancy [74].
The placenta appears to be the major source for the conversion of angiotensin I 
into ANG-II, since the prorenin, active renin, angiotensin converting enzyme (ACE), 
and ANG-II have been identified in the chorion and in the placenta [88]. The physi-
ological roles of these components have not been completely clarified, but it has been 
speculated that they might participate in the regulation of the blood flow [89–92].
The increase in renin concentrations during pregnancy has also been attrib-
uted to the loss of electrolytes as a consequence of the increase in the glomerular 
filtration rate as well as of the secretion of P4, due to the antagonic effects of the 
hormone on aldosterone, because P4 induces natriuresis [74, 76, 93]. On the other 
hand, the positive influence of E2 on the synthesis of angiotensinogen has also 
been considered a plausible reason for the renin peak during pregnancy [76]. 
Surprisingly, it is possible to find increased renin concentrations without a simulta-
neous increase of ANG-II concentrations. In addition, the sequestration of Na and 
water at the uterus might be another triggering factor for the release of renin during 
pregnancy, as documented in pregnant bitches [94].
In pregnant mares, Satué et al. [95] described a significant increase in the renin 
from the seventh month of pregnancy (Figure 8). In pregnant women, as stated 
before, the increase in renin concentrations occurs earlier than in the pregnant 
mares [79, 80, 84]. At present, it is unknown if the origin of these differences is the 
different animal species or it could be due to the influence of other physiological 
factors. In the mare, ANG-II concentrations did not vary significantly during preg-
nancy (Figure 9), despite the changes in renin concentrations (Figure 8). These 
data might suggest that there is a dissociation between renin and ANG-II during 
pregnancy in the mares. In pregnant women, it has been shown that the increase in 
Figure 8. 
Mean (maximum and minimum indicated in bars) concentrations of renin in mares during pregnancy 
(significant differences between months indicated with numbers at p < 0.05).
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Figure 9. 
Mean (maximum and minimum indicated in bars) concentrations of angiotensin II in mares during 
pregnancy.
ANG-II exerts a negative feedback effect on renin secretion [74, 85, 96]. In addition, 
it has been proposed that the peak of renin during pregnancy is in part associated 
with the release of estrogens, which act on the production of angiotensinogen in the 
liver [15, 76, 97]. Moreover, Satué et al. [98] found a dissociation between renin and 
E2, in agreement with previous results described for pregnant women [77, 99].
On the contrary to the data found for ANG-II in mares [95], most of the 
investigations performed in women and laboratory animals showed that during 
pregnancy, circulating concentrations of ANG-II increased up to two and even three 
times from nonpregnant values [74, 78, 100, 101]. This increase in women appears 
from the beginning of the pregnancy, peaking at the seventh month and persisting 
to be elevated until the moment of the delivery [102].
Pregnant mares showed a marked increase in circulating aldosterone concentra-
tions during pregnancy, with mean values that exceed almost 12 times the physiologi-
cal reference range for healthy adult horses [103] (Figure 10). Similar results have been 
reported in pregnant women [74, 84, 104], bitches [105–107], and some species of 
laboratory animals [108]. In pregnant bitches, Robb et al. [94] and in rats, Brochu et al.  
[106] attributed the increase in aldosterone concentrations to a higher activity of the 
enzyme aldosterone-synthase and to an increased synthesis of mRNA in the cells of 
the zona glomerulosa, these cells being the only production site, without fetal and/or 
placental participation, on the contrary of what appears to happen in women [78].
In mares, our team has found lower aldosterone concentrations during the 
second month of pregnancy, compared to the fifth, sixth, and seventh months 
of pregnancy (Figure 10). The highest values were observed in the fifth month 
of pregnancy. In the eighth, ninth, and tenth months of pregnancy, aldosterone 
concentrations were significantly lower than the mean values found in the fifth 
month. In pregnant women, it has been speculated that the increased release of 
aldosterone would occur in an attempt to conserve Na and water to favor the expan-
sion of the fetoplacental unit. In this way, the adequate supply of nutrients to the 
fetus, the maintenance of the ideal oxygen tension for fetal development, as well as 
the homeostasis and appropriate blood pressure between the mother and the fetus 
would be guaranteed [108, 109].
13
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Although the evolution of aldosterone concentrations during pregnancy is similar in 
women, laboratory animals, and mares, there are temporary differences in the moment 
in which the peaks of concentrations are reached. In women and laboratory animals, the 
maximum increase in aldosterone appears in the second third of pregnancy, followed 
by a decrease in the third period of pregnancy. In the mare, on the contrary, as shown in 
Figure 10, the maximum concentrations were found in the fifth month.
The increase in aldosterone during pregnancy in women has been attributed, 
firstly, to the increase in the sensitivity of the cells of the adrenal gland to the 
increased synthesis and release of renin [74, 110] and, secondly, to the increase 
in ANG-II concentrations, a finding that has been associated with an increase 
in placental lactogen [74]. In women, it is known that placental lactogen plays a 
regulatory role in metabolic homeostasis, triggering an increase in ANG-II receptors 
during the second period of the pregnancy [111, 112]. It has also been speculated 
in women that the increase in the concentrations of aldosterone during pregnancy 
could be a decisive physiological event in order to prevent the massive natriuresis 
that could arise from an enhanced glomerular filtration rate. In these cases, aldo-
sterone shows a physiological action opposite to the natriuretic effect of P4 at the 
level of the distal convoluted tubule, avoiding excessive loss of Na and allowing its 
gradual accumulation in the fetoplacental and in the extracellular maternal fluids 
[113]. However, the antagonism between both mineralocorticoids, i.e., aldosterone 
and P4, during pregnancy does not seem to be constant [114, 115].
4. Conclusions
Our results obtained in healthy reproductive mares demonstrated that there is an 
activation of the RAAS around the time of ovulation, as indicated by the increased 
plasma renin and aldosterone concentrations. After ovulation, the rapid decrease in 
plasma renin and ANG-II concentrations might indicate a modulation of the previ-
ously activated RAAS, even though plasma aldosterone concentrations increased 
during this period, suggesting a dissociation of the components of this system.
Figure 10. 
Mean (maximum and minimum indicated in bars) concentrations of aldosterone in mares during pregnancy 
(significant differences between months indicated with numbers at p < 0.05).
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In the pregnant mare, there is also an increased activity of various components 
of the RAAS. Pregnant mares show a progressive increase in circulating renin, 
with fluctuating changes in aldosterone, peaking at fifth month of pregnancy and 
without significant changes in ANG-II. The reason for the apparent dissociation 
between the three main hormones of the RAAS at determined moments of the preg-
nancy remains unclear. The data obtained in pregnant mares regarding the RAAS 
seems to indicate that renin is a more intense stimulus for the increased synthesis of 
aldosterone than ANG-II.
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